Scout Investments’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-236,146
Closed -$58M 230
2022
Q3
$58M Buy
236,146
+40,276
+21% +$10.9M 1.2% 16
2022
Q2
$48.5M Buy
195,870
+10,279
+6% +$2.77M 0.96% 25
2022
Q1
$61.5M Sell
185,591
-9,373
-5% -$2.89M 0.98% 26
2021
Q4
$70M Buy
194,964
+84,217
+76% +$28.5M 1.02% 16
2021
Q3
$36M Buy
110,747
+25,108
+29% +$8.51M 0.54% 54
2021
Q2
$26.7M Sell
85,639
-21,943
-20% -$6.73M 0.4% 91
2021
Q1
$34.3M Buy
107,582
+28,566
+36% +$9.14M 0.52% 61
2020
Q4
$25.6M Sell
79,016
-4,393
-5% -$1.22M 0.47% 66
2020
Q3
$23.1M Sell
83,409
-37,903
-31% -$10.9M 0.51% 59
2020
Q2
$29.3M Buy
+121,312
New +$24.4M 0.7% 32
2019
Q4
Sell
-165,487
Closed -$29.4M 294
2019
Q3
$29.4M Sell
165,487
-61,760
-27% -$13.4M 0.59% 57
2019
Q2
$59.2M Buy
227,247
+110,435
+95% +$29.3M 1.14% 14
2019
Q1
$33.4M Buy
116,812
+19,751
+20% +$6.56M 0.68% 38
2018
Q4
$31.5M Sell
97,061
-27,044
-22% -$9.39M 0.79% 34
2018
Q3
$55.8M Sell
124,105
-216,742
-64% -$85.4M 1.15% 8
2018
Q2
$139M Sell
340,847
-29,149
-8% -$10.6M 3.17% 1
2018
Q1
$108M Sell
369,996
-92,062
-20% -$23.3M 2.58% 2
2017
Q4
$86.6M Sell
462,058
-89,891
-16% -$16.8M 2.14% 2
2017
Q3
$93.1M Buy
551,949
+17,706
+3% +$2.68M 2.55% 2
2017
Q2
$76.6M Sell
534,243
-16,354
-3% -$2.2M 2.22% 2
2017
Q1
$68.9M Buy
550,597
+40,217
+8% +$4.66M 1.89% 3
2016
Q4
$57.5M Buy
510,380
+49,099
+11% +$5.69M 1.6% 6
2016
Q3
$59.3M Buy
461,281
+192,214
+71% +$23M 1.66% 5
2016
Q2
$29.4M Sell
269,067
-62,436
-19% -$6.21M 0.82% 25
2016
Q1
$31.4M Buy
331,503
+40,494
+14% +$3.42M 0.86% 36
2015
Q4
$26.3M Buy
291,009
+109,577
+60% +$9.3M 0.66% 58
2015
Q3
$16.8M Buy
+181,432
New +$16M 0.39% 99

Other funds holding ABMD

Scout Investments's ABMD Position: Q4 2022 in Review

Scout Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 236,146 shares — an estimated $58M sold.

Scout Investments first reported a position in ABMD in Q3 2015 and held it in 27 quarters. The position peaked at $139M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Scout Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Scout Investments sold 236,146 Abiomed Inc shares in Q4 2022, an estimated $58M.
  • Scout Investments first reported a position in Abiomed Inc in Q3 2015 and held it in 27 quarters.
  • Scout Investments's Abiomed Inc position peaked at $139M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Scout Investments's 13F filing for Q4 2022, filed 23 Jan 2023.